PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1871287
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1871287
Vascular Graft Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
The Global Vascular Graft Market was valued at USD 3.6 billion in 2024 and is estimated to grow at a CAGR of 6.9% to reach USD 7.3 billion by 2034.
The market expansion is driven by the rising prevalence of cardiovascular disorders, technological innovations, and the growing incidence of end-stage renal disease (ESRD), along with an increase in surgical interventions worldwide. Vascular grafts are medical devices designed to replace, repair, or bypass damaged or diseased blood vessels, restoring normal blood flow. These grafts are manufactured from synthetic materials, biological tissues, or a hybrid of both. They are widely used in treatments for cardiovascular conditions, aneurysms, and hemodialysis access. Recent advancements, such as bioengineered grafts, heparin-coated ePTFE grafts, and hybrid materials, enhance compatibility, reduce thrombosis risk, and improve long-term patency. The market is also benefiting from the growing preference for minimally invasive and endovascular procedures, increasing use of tissue-engineered and biodegradable grafts, adoption of drug-eluting and coated grafts, and expansion in emerging markets, collectively propelling industry growth.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $3.6 Billion |
| Forecast Value | $7.3 Billion |
| CAGR | 6.9% |
The polyester grafts segment held a 62.3% share in 2024. Polyester grafts are preferred for their durability, excellent biocompatibility, and proven long-term patency in vascular repair and bypass procedures. Their extensive clinical history and consistent performance in aortic and peripheral bypass surgeries have earned them high trust among surgeons, making them a staple in vascular procedures.
The hemodialysis access segment is expected to grow at a CAGR of 6.3% through 2034. Rising cases of ESRD and an increasing number of patients requiring long-term hemodialysis are driving demand for vascular grafts. Innovations in graft design that improve patency and minimize infection risks further support growth in this segment.
North America Vascular Graft Market held a 32.2% share in 2024. High rates of coronary artery disease, peripheral artery disease, and aortic aneurysms contribute to the region's strong demand. Well-established hospitals with specialized vascular surgery centers and access to advanced surgical technologies support the adoption of both open and endovascular graft procedures.
Key players in the Global Vascular Graft Market include Cook Medical, Gore, Terumo, Medtronic, B. Braun, Merit Medical Systems, LeMaitre, Abbott, Endologix, Vascular Graft Solutions, MicroPort, Artivion, BD (Becton, Dickinson & Company), Getinge, and Cordis. Companies in the Vascular Graft Market are adopting multiple strategies to strengthen their market position. They are heavily investing in research and development to create innovative grafts with improved patency, biocompatibility, and reduced complication risks. Strategic mergers, acquisitions, and partnerships help expand product portfolios and regional reach. Many firms focus on technological advancements, including drug-eluting, bioengineered, and hybrid grafts. Marketing campaigns, surgeon education programs, and strong hospital collaborations improve brand recognition and trust.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 3600 synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Raw Material trends
- 2.2.3 Application trends
- 2.2.4 End use trends
- 2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
- 2.4 Future outlook and strategic recommendations
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing number chronic diseases worldwide
- 3.2.1.2 Growing number of end-stage renal disorders in developing economies
- 3.2.1.3 Technological advancements in developed countries
- 3.2.1.4 Rise in organ transplantation
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Lack of skilled personnel in developing countries
- 3.2.2.2 Risk of graft infection and thrombosis
- 3.2.3 Market opportunities
- 3.2.3.1 Development of bioresorbable and hybrid grafts
- 3.2.3.2 Rising adoption of 3D printing in graft development
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Reimbursement scenario
- 3.5 Regulatory landscape
- 3.5.1 North America
- 3.5.2 Europe
- 3.5.3 Asia Pacific
- 3.5.4 LAMEA
- 3.6 Technology landscape
- 3.6.1 Current technological trends
- 3.6.2 Emerging technologies
- 3.7 Consumer analysis
- 3.8 Value chain analysis
- 3.9 Future market trends
- 3.10 Key investment and expansion trends
- 3.11 Overview of graft types
- 3.12 Innovations in graft materials and coatings
- 3.13 Porter's analysis
- 3.14 PESTEL analysis
- 3.15 Gap analysis
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.3.5 LAMEA
- 4.4 Competitive positioning matrix
- 4.5 Competitive analysis of major market players
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New raw material launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Raw Material, 2021 - 2034 ($ Mn)
- 5.1 Key trends
- 5.2 Polyester grafts
- 5.3 ePTFE grafts
- 5.4 Biosynthetic grafts
- 5.5 Polyurethane grafts
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
- 6.1 Key trends
- 6.2 Endovascular aneurysm repair
- 6.2.1 Abdominal aortic aneurysm repair
- 6.2.2 Thoracic aortic aneurysm repair
- 6.3 Hemodialysis access
- 6.4 Peripheral vascular repair
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centers
- 7.4 Other end use
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
Chapter 9 Company Profiles
- 9.1 Abbott
- 9.2 Artivion
- 9.3 B. Braun
- 9.4 BD (Becton, Dickinson & Company)
- 9.5 Cook Medical
- 9.6 Cordis
- 9.7 Endologix
- 9.8 Getinge
- 9.9 Gore
- 9.10 LeMaitre
- 9.11 Medtronic
- 9.12 Merit Medical Systems
- 9.13 MicroPort
- 9.14 Terumo
- 9.15 Vascular Graft Solutions
